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N-acetylcysteineBackground: CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO – a critical
gasotransmitter – in biological environments. CO-RMs are also effective antimicrobial agents; although the
mechanisms of action are poorly deﬁned, haem-containing terminal oxidases are primary targets. Nevertheless,
it is clear from several studies that the effects of CO-RMs on biological systems are frequently not adequately
explained by the release of CO: CO-RMs are generally more potent inhibitors than is CO gas and other effects
of the molecules are evident. Methods: Because sensitivity to CO-RMs cannot be predicted by sensitivity to CO
gas, we assess the differential susceptibilities of strains, each expressing only one of the three terminal oxidases
of E. coli— cytochrome bd-I, cytochrome bd-II and cytochrome bo′, to inhibition by CORM-3.We present the ﬁrst
sensitive measurement of the oxygen afﬁnity of cytochrome bd-II (Km 0.24 μM) employing globin deoxygen-
ation. Finally, we investigate the way(s) in which thiol compounds abolish the inhibitory effects of CORM-2
and CORM-3 on respiration, growth and viability, a phenomenon that is well documented, but poorly under-
stood. Results: We show that a strain expressing cytochrome bd-I as the sole oxidase is least susceptible to inhi-
bition by CORM-3 in its growth and respiration of both intact cells and membranes. Growth studies show that
cytochrome bd-II has similar CORM-3 sensitivity to cytochrome bo′. Cytochromes bo′ and bd-II also have consid-
erably lower afﬁnities for oxygen than bd-I. We show that the ability of N-acetylcysteine to abrogate the toxic
effects of CO-RMs is not attributable to its antioxidant effects, or prevention of CO targeting to the oxidases,
but may be largely due to the inhibition of CO-RM uptake by bacterial cells. Conclusions: A strain expressing
cytochrome bd-I as the sole terminal oxidase is least susceptible to inhibition by CORM-3. N-acetylcysteine is a
potent inhibitor of CO-RM uptake by E. coli. General signiﬁcance: Rational design and exploitation of CO-RMs
require a fundamental understanding of their activity. CO and CO-RMs havemultifaceted effects on mammalian
and microbial cells; here we show that the quinol oxidases of E. coli are differentially sensitive to CORM-3. This
article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins.
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Carbon monoxide (CO) inhibits respiration by binding to haems,
particularly the terminal oxidases and globins of aerobic respiration
[1]. However, since 1991 [2], CO has come to be recognised as an im-
portant endogenous gas with beneﬁcial roles at low concentrations
[3]. CO is produced endogenously by haem oxygenases, functions as a
neural messenger [4] and also has vasodilatory [5], anti-inﬂammatory
and anti-apoptotic properties [6].
The discovery of the beneﬁcial effects of low concentrations of CO
has prompted research into the use of CO as a human therapeutic
agent [7]. Due to the obvious dangers of CO inhalation therapy, CO
carriers, analogous to NO-releasing compounds, were developed
speciﬁcally for medical applications; the ﬁrst such report was a patent
Fig. 1. The structure of the CO-RM compounds used in this work. (A) CORM-3,
(B) CORM-2 and (C) RuCl2(DMSO)4, the compound used as a control for experiments
with CORM-2.
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CO-RMs, have diverse biological effects, similar in many respects, but
not identical, to those of CO [9], including vasodilation [10–12], reduc-
ing inﬂammation [13,14] and cardiac graft rejection [15,16].
However, it is important to note that numerous studies show
clearly that the biological effects of CO-RMs cannot be wholly
explained by the liberation of CO. That is, the effects of CO-RMs are
not precisely replicated by additions of CO gas solutions. For example,
Nobre [17] showed that both CORM-2 and CORM-3 were more potent
antibacterial agents than CO gas. Additionally, CORM-3 is inhibitory
to bacterial growth at micromolar concentrations and at atmospheric
oxygen levels [18], whereas it is generally understood that CO must
be present in signiﬁcant excess over oxygen [1] (typically in a ratio
of 19:1) [19] to be inhibitory. Furthermore, even saturated solutions
of CO gas (approx. 1 mM) are known to allow bacterial growth [20]
whereas only 100 μM CORM-3 or less is highly toxic to aerobic E. coli
cultures [18]. CORM-3 also inhibits respiration of cells, after transiently
accelerating oxygen uptake by an uncoupler-independent mechanism,
and promotes cation transport across spheroplast membranes, yet
these effects are not mimicked by CO gas [21].
Previous work has shown that a range of CO-RMs are bactericidal
against Staphylococcus aureus and E. coli [17] and that CORM-3 increases
survival in mice infected with Pseudomonas aeruginosa [22]. We previ-
ously identiﬁed the aerobic respiratory chain as a direct bacterial target
in E. coli by demonstrating that CO from CORM-3 is delivered directly to
intracellular cytochromes bd and bo′ of the aerobic respiratory chains
[18]. Further evidence that the inhibition of respiration is due mainly
to binding of CO from CO-RMs to oxidases comes from the reversal of
CORM-3-mediated respiratory and growth inhibition by photolysis of
the haem–CO bond [21].
However, unexpected, non-haem protein targets exist, such as, in
bacteria, diverse transport processes [21] and the metabolism, ho-
meostasis, and transport of metals [18]. In higher cells, CO activates
large-conductance Ca2+- and voltage-gated K+ (Slo1 BK) channels,
which are involved in oxygen sensing, vasodilation, and the activa-
tion of signalling from neurones [23]. The interaction of CO with
such channels involves sulfur from cysteine and nitrogen from histi-
dine residues within the cytoplasmic domain of the channel. CO is
thought to act as a partial agonist for the divalent cation sensor in
the Slo1 BK channel [24]. CO is also known to bind to iron in Fe, Fe–
Fe and Fe–Ni hydrogenases [25], to the Fe–Fe hydrogenases of
Chlamydomonas [26] and to binuclear copper sites as in tyrosinase
[27] and haemocyanins [28,29].
It has been noted in several studies that the thiol compound
N-acetylcysteine (NAC) abolishes the biological activities of metal-
containing CO-RMs, preventing induction of HO-1 expression and
haem oxygenase activity in murine macrophages by CORM-3 [13],
and relieving inhibitory effects of CORM-2 on the mitochondrial re-
spiratory chain and NAD(P)H oxidase [30]. More recently, several
thiol compounds have been found to prevent the effects of CORM-3
on the growth and oxygen consumption of P. aeruginosa [22]. Several
hypotheses have been proposed to explain this. Tavares et al. [31]
have suggested that such compounds nullify the activity of CO-RMs
by virtue of their antioxidant properties, as high concentrations of
CORM-2 cause an increase in reactive oxygen species (ROS), which
is diminished by exogenous glutathione. Desmard et al. [22] also
investigated this possibility but found that 100 μM CORM-2,
CORM-3, CORM-371 or CORM-A1 did not cause any ROS production
in P. aeruginosa within 1 h of treatment as measured by DCFH-DA
(2′7′-dichloroﬂurescin diacetate).
Terminal oxidases may be prime determinants of sensitivity to
CO-RMs in their antimicrobial activities. The three terminal oxidases
of E. coli have distinctive properties. It is tacitly assumed that these
differences in afﬁnity for oxygen [32], contributions to proton translo-
cation [33] and patterns of expression as a result of transcriptional
regulation [34,35] are reﬂected in their physiological roles and ﬁtnessfor particular environmental niches. Here we assess the differential
susceptibilities of bacteria possessing each of the three terminal oxi-
dases of E. coli – cytochromes bd-I, bd-II and bo′ – to CORM-3. We re-
port growth studies and measurements of respiration in the presence
of CORM-3. We also test the hypothesis that N-acetylcysteine may
lower CO-RM uptake, and suggest that this probably explains, in
part, the ability of the thiol to interfere with the toxic effects of both
CORM-2 and CORM-3.
2. Materials and methods
2.1. E. coli strains and growth conditions
All E. coli strains used were K-12 derivatives; MG1655 (RKP5416)
was the wild type [36] fromwhich the respiratory mutants, TBE023, re-
ferred to throughout this paper as the parent strain (MG1655 Δ nuoB::
kan), TBE025 referred to as Cyo+ (MG1655 ΔcydB nuoB appB::kan),
TBE026 referred to as App+ (MG1655 ΔcydB nuoB cyoB::kan) and
TBE037 referred to as Cyd+ (MG1655 ΔappB nuoB cyoB::kan) were de-
rived (mutants kindly given by Alex Ter Beek and Joost Teixeira de
Mattos, University of Amsterdam). These strains carry the samemutant
alleles as described by Bekker et al. [37]. Unless stated otherwise, E. coli
cultures were grown aerobically in deﬁnedminimalmediumwith glyc-
erol (54 mM) as a carbon source [18]. For growth studies, cultures were
grownwith or without 12.5 μMCORM-3 (added at an optical density of
30 Klett units) in 30 ml medium in 250 ml conical ﬂasks ﬁtted with
side arms for measurements of optical density with a Klett meter with
a no. 66 (red) ﬁlter (Klett Manufacturing Co., New York, N.Y.). Cultures
were incubated at 37 °C and shaken at 200 rpm.
2.2. Preparation of E. coli membrane particles
E. coli cells were grown in 1 l LB broth in 2 l bafﬂed ﬂasks at 37 °C
with shaking at 250 rpm until mid-exponential phase. Membranes
were prepared as described previously [38]. Protein concentrations
were measured using a modiﬁed Lowry procedure [39].
2.3. CO-RM and control treatments
The CO-RMs used in this studywere tricarbonyldichlororuthenium(II)
dimer ([Ru(CO)3Cl2]2), referred to as CORM-2 [40] and Ru(CO)3-
Cl(glycinate), referred to as CORM-3 [15]; the structures of these com-
pounds are shown in Fig. 1A and B. CORM-2 was purchased from
Sigma Aldrich and prepared as a 10 mM stock solution in DMSO.
CORM-3 was synthesised as previously described [41]. Stock solutions
(10 mM or 100 mM) were made by dissolving in water and stored on
ice. CORM-2 stocks were kept in the dark and used within 1 h, while
CORM-3 stocks were used fresh or on the following day after storage
at 4 °C.
Two different control molecules were used. RuCl2(DMSO)4, used
as a control for CORM-2, was supplied by Dr. Tony Johnson (Chemis-
try Department, The University of Shefﬁeld) and stock solutions
(10 mM) were made fresh each day by dissolving in water. The struc-
ture of this compound is shown in Fig. 1C [42]; this compound was
used in Fig. 2. The second control compound, inactive iCORM-3 was
Fig. 2. CO, CORM-3 and CORM-2 inhibit respiration inwild type E. colimembraneparticles.
Wild type E. colimembraneparticleswere added to an oxygen electrode chamber in buffer
(2 ml) to a ﬁnal concentration of approximately (A) 60 μg/ml, (B) 170 μg/ml, or
(C) 100 μg/ml. The chamber was closed and respiration was initiated by the addition of
6.25 mM NADH. CO and CO-RMs were then added as indicated at approximately 75% of
oxygen saturation (310 nmol O2 in the chamber). Traces show dissolved oxygen in the
chamber as follows: (A) control (black solid line) and 100 μM CO (blue broken line);
(B) control (black solid line), 100 μM iCORM-3 (red dot dash line), 100 μM CORM-3
(blue short dash line), 400 μM CORM-3 (blue long dash line); (C) control (black solid
line), 100 μM RuCl2(DMSO)4 (red dot dash line), 50 μM CORM-2 (blue short dash line),
100 μM CORM-2 (blue long dash line). Respiration rates (nmol min−1 mg−1 protein)
2 min following the addition of CO-RM are shown adjacent to each trace. These data are
representative of at least 3 technical and 2 biological replicates.
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phosphate-buffered saline (PBS), and bubbling with O2-free nitrogen
(BOC, Guildford, GU2 5XY) at regular intervals over 2 h. After such
time, little CO release can be detected (less than 5% than of the
same concentration of CORM-3) in a myoglobin assay (see below).
This process is thought to release labile CO, which escapes upon bub-
bling, leaving a CO-depleted iCORM-3 compound in solution [15].
However, growing evidence suggests that CORM-3 is unable to re-
lease large quantities of CO under these conditions, but rather the car-
bonyl compound is altered forming a stable species that releases CO
more slowly [15,44–46]. This inactivation could produce a very slow
CO-releasing tri-carbonyl complex [41] or a di-carbonyl compound,
which is formed via the release of CO2 from CORM-3 [45]. It is ac-
knowledged that iCORM-3 is an imperfect control, since it has not
been exposed to biological molecules or intracellular species that
may induce release of more CO and its structure is not known. How-
ever, iCORM-3 has been used as a control compound for CORM-3 by
several research groups [15,45] and a recent paper [47] has revealed
the transcriptomic response of E. coli to this compound, allowing fur-
ther clariﬁcation as to which transcriptomic changes result from CO
release from CO‐RMs, and which from the ruthenium compound de-
void of labile CO. The advantage of iCORM-3 is that it is produced di-
rectly from the CORM-3 molecule and is therefore much more likely
to mimic the compound present in vivo after CO has been released
[47].
CO release from both CORM-3 and iCORM-3 to ferrous myoglobin
was assayed as before [15,44] in a dual-wavelength scanning spectro-
photometer [48]. Data were plotted as the difference between the
spectrum of a CORM-3-reacted and reduced sample minus the spec-
trum of a reduced sample [49]. Where indicated, CO was added as a
saturated solution made by bubbling from a cylinder (BOC, Guildford,
GU2 5XY) at room temperature for 15 min.
2.4. Measurement of O2 consumption
E. coli membrane particles were suspended in sonication buffer
(50 mM Tris–HCl, 2 mM MgCl2 and 1 mM EGTA, pH 7.4) in a stirred
Perspex chamber ﬁtted with a Clark-type polarographic O2 electrode
(OXY041A, Rank Bros Ltd., Bottisham, CB25 9DA) held at 37 °C [50].
Both open and closed O2 electrode systems were used. In closed exper-
iments, NADH (6.25 mM) was added to stimulate respiration and the
CO-RM compound or CO-saturated solution was added when the
dissolved oxygen tension in the chamber reached approximately155 μM. In open electrode experiments, the chamber was initially
closed and NADH (6.25 mMor 12.5 mM)was added to stimulate respi-
ration. Compound(s) were added 1 min after the dissolved oxygen ten-
sion in the chamber reached anoxia and the lid removed 1 min later.
This allowed continuous O2 diffusion from the vortex surface into the
sample at a rate that is deﬁned by KLa, the gas transfer coefﬁcient
from gas to liquid. This constant is dictated by the reaction volume, sur-
face area and temperature [51], all of which were rigorously controlled
and quantiﬁed. A typical KLa value, i.e. the rate constant for the half-
time of oxygen diffusion into anoxic medium from the atmosphere,
was 0.35 min−1. The extent of respiratory inhibition was determined
by measuring the time to oxygen re-accumulation after removal of
the chamber lid, as previously described [52]. This method has the dis-
tinct advantage, as exploited before [52,53], that prolonged measure-
ments can be made without exhaustion of oxygen.
2.5. UV–visible spectroscopy
Difference spectra (i.e. the difference between the spectrum of a
CORM-3-reacted and reduced sample minus the spectrum of a reduced
sample) of E. coli membrane particles suspended in sonication buffer
(8–19 mg/ml) were recorded in a dual wavelength spectrophotometer
[48] using a 10 mm path length cuvette. Membranes were reduced by
the addition of a few grains of dithionite and then treated with
CORM-3 (100 μM) or CO bubbling. Spectra were recorded in triplicate.
Where appropriate, CORM-3 was pre-incubated for 5 min with NAC
(1 mM) prior to addition to the membranes.
2.6. The deoxygenation of oxyleghaemoglobin by membranes containing
only cytochrome bd-II
Determination of oxygen afﬁnities was carried out as described pre-
viously by D'mello et al. [32]. Oxygenated soybean leghaemoglobin
(kindly donated by Dr. C. Appleby) was diluted to 10–20 μM in phos-
phate buffer (50 mM, pH 7.4) containing 1 mM EDTA. Deoxygenation
of the globin by respiration of themembraneswasmonitored using clas-
sical dual wavelength spectrophotometry as described by Kalnenieks et
al. [48]; themeasuringmonochromaterwas set at 558 nmand the refer-
ence at 577 nm. The custom-made 1.3 ml capacity cuvette was ﬁlled
with the globin solution and sealed with a ﬁnely perforated stopper,
through which substrate solution (NADH, 3 mM) was injected. The
stability of the oxygenated globin was checked by monitoring ΔA for
5–10 min. After addition of membranes, globin deoxygenationwas con-
tinuously monitored by plotting ΔA577–558. Data were analysed as de-
scribed previously by D'mello et al. [54]. Four separate determinations
were carried out on each sample; means and standard deviations are
given.
2.7. Ruthenium uptake by growing cells
Either CORM-3 (40 μM) alone or with NAC (400 μM) or CORM-2
(20 μM) alone or with NAC (200 μM) was added during logarithmic
phase to aerobic cultures of E. coli grown in Evans medium [55]. This
medium was used for this work to maintain consistency with other
metal uptake analyses done within this laboratory [47]. Samples
(20 ml) were taken before the addition of CORM-3 and at intervals
thereafter. Cells were harvested by centrifugation at 5500 rpm for
5 min in polypropylene tubes (50 ml). Culture supernatants were
retained for analysis. Cell pellets were washed three times in 0.5%
HNO3 (0.5 ml each; Aristar nitric acid (69%, v/v)) to remove loosely
bound elements. Supernatants collected from the washes were also
retained for analysis. Samples were analysed using a Spectro CirosCCD
(Spectro Analytical) inductively coupled plasma-atomic emission spec-
trometer (ICP-MS). The percentage of ruthenium recovered from these
samples varied from 74 to 90% of the total added to the cultures. To
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individual cell dry mass and volume were used [56].
3. Results
3.1. CORM-2, CORM-3 and CO inhibit respiration in E. coli membrane
particles
In many previous studies by others and ourselves, summarised in
the Introduction, CO-RMs have been shown to be more effective in-
hibitors of growth and respiration than is CO administered as a solu-
tion of the gas (for example [17,18,21]). It is thought that this may be
due in part to an accumulation of CORM-3 inside bacterial cells lead-
ing to high CO concentrations at the target site(s) [18]. CORM-3 re-
leases 1 mol of CO for each mole of CO-RM [15] whereas CORM-2
releases 0.7 mol of CO for each mole of compound [40] and these stoi-
chiometries are unchanged by factors such as sulﬁte species that
change only the rate of CO release [47]. We investigated the effects
of CORM-2, CORM-3 and CO gas on respiration in membrane particles
prepared from wild type E. coli. Unlike previous studies with intact
bacteria, CO (100 μM) signiﬁcantly inhibited respiration of mem-
brane particles (by 38% at 2 min following the addition of CO), and
to a greater extent than 100 μM CORM-3 (12%) (Fig. 2A and B).
CORM-2 was found to be more inhibitory to respiration than
CORM-3; 100 μM CORM-2 inhibited respiration of wild type E. coli
membrane particles by 85% (Fig. 2C). In contrast, 400 μM CORM-3
inhibited respiration by only 55% of the control rate, as measured
2 min following CORM-3 addition. This is in agreement with the ﬁnd-
ings of Nobre et al. [17] who found that higher concentrations of
CORM-3 than CORM-2 were required to decrease viability in E. coli
and S. aureus cultures. Importantly, the control compounds iCORM-3
and RuCl2(DMSO)4 had no signiﬁcant inhibitory effects on respiration:
100 μM iCORM-3 inhibited respiration by 6% of the control rate,
while addition of 100 μM RuCl2(DMSO)4 had no effect on the respi-
ration rate.
3.2. Cells expressing only cytochrome bd-I as sole oxidase are least
susceptible to inhibition by CORM-3
Inhibition of respiration by CO from CORM-3 is thought to be one
of the major mechanisms of killing by the metal carbonyl compound
[18,21,22], but is probably not wholly responsible for the toxic effects.
Previous work has conﬁrmed that CO from CORM-3 is internalised by
E. coli cells and binds to the terminal oxidases of the aerobic respira-
tory chain [18]. In order to understand better the mechanism of respi-
ratory inhibition by CORM-3, and because most bacteria (unlike
mitochondria) possess numerous distinct oxidases, we asked wheth-
er mutants expressing each of the three oxidases of E. coli differ in
their sensitivity to this well-characterised, water-soluble CO-RM
and the CO released from it. Growth of mutants was assessed in the
presence of 12.5 μM CORM-3 (Fig. 3). The levels of oxidases present
in these strains are those resulting from the natural promoter
strengths without use of inducers; precise control or standardisation
of levels of oxidase expression is impractical. The strain containing
cytochrome bd-I only was found to be most resistant to growth inhi-
bition in the presence of CORM-3 (Fig. 3B, E) and the strains express-
ing cytochromes bd-II or bo′ as the only oxidase were found to be
most sensitive (Fig. 3C, D, and E). The relative resistance to CORM-3
of the strain containing only cytochrome bd-I is reminiscent of the re-
sistance of this oxidase to NO [57], cyanide [58] and other inhibitors
[59].
In light of this ﬁnding, membrane particles prepared from these
single oxidase-expressing E. coli mutants were assessed for their sus-
ceptibility to respiratory inhibition by CORM-3. In this experiment, in
view of the slow and incomplete inhibition of respiration (Fig. 2), we
used an open electrode experimental design in which inhibition canbe monitored over an hour or more, as before [21]. An oxygen elec-
trode was used to monitor the dissolved oxygen concentration in a
sample of E. coli membrane particles, which were stimulated to re-
spire by the addition of NADH. Following the complete depletion of
oxygen from the sample, CORM-3 was added and the lid of the cham-
ber removed allowing oxygen to enter the system. The extent of re-
spiratory inhibition was determined by measuring the time taken
for oxygen re-accumulation to begin after removal of the chamber
lid, in the presence of CORM-3. The respiration of a more sensitive
strain will be inhibited to a greater extent, leading to a shorter time
to reoxygenation [52,53].
When respiring membrane particles containing either cytochrome
bd-II (App+) or all three oxidases (parent strain) were treated with
100 μM CORM-3, the time taken for the chamber to reoxygenate
was signiﬁcantly reduced (by 80–82%) (Fig. 4A) compared to when
no compound was added (Fig. 4B). Thus, CORM-3 signiﬁcantly in-
hibits respiration in these strains. However, when membrane parti-
cles prepared from a strain expressing only cytochrome bd-I (Cyd+)
were treated with 100 μM CORM-3, the time to reoxygenation of
the electrode chamber was reduced by only 7% compared to that
when no compound was added. This conﬁrms that membranes
possessing only cytochrome bd-I are the most resistant to CORM-3.
These results are summarised in Fig. 4C. Attempts were made to per-
form this experiment using membranes expressing cytochrome bo′ as
the only terminal oxidase; however, due to the much slower respira-
tion rate of this strain, it was not possible for the chamber to maintain
an oxygen tension of 0% for an extended period of time in the control
experiment in which no compound was added.
The oxidase composition of the respiratory mutants used in this
work was conﬁrmed by identiﬁcation of the CO-reactive cytochromes
(Fig. 5). Here we show CORM-3 difference spectra (i.e. the difference
between the spectrum of a CORM-3-reacted and reduced sample
minus the spectrum of a reduced sample) of membrane particles pre-
pared from the single oxidase-expressing strains. In Fig. 5A–C, the
Soret feature consisting of a peak near 420 nm (417–424 nm) and
the trough at 445–447 nm demonstrate the binding of CO from
CORM-3 to the bd-type oxidase [60,61]. In the case of Cyo+ mem-
branes (Fig. 5D), the presence of cytochrome o′ is revealed by a mark-
edly blue-shifted absorbance minimum at 433 nm (due to loss of the
ferrous cytochrome o′) accompanied by a 415 nm peak (due to
formation of the Fe(II)–CO adduct) [62]. The signals in the near-red
region are more informative; the peak at 644–646 nm is diagnostic
of the binding of CO to cytochrome d exclusively, whilst the minimum
at 626–632 is due to loss of absorbance of the Fe(II) form of haem d
(Fig. 5A–C). Cytochrome bo′ does not exhibit bands in this region
and, accordingly, the CORM-3 difference spectrum of Cyo+membranes
(Fig. 5D) is featureless beyond about 580 nm.
3.3. Determination of the oxygen afﬁnity of cytochrome bd-II inmembranes
by deoxygenation of oxyleghaemoglobin
Several authors report the oxygen afﬁnities of cytochromes bo′ and
bd-I in E. coli [63–65] but most of these rely on the use of membrane-
covered oxygen electrodes, which cannot provide the sensitivity
required for enzymeswith such high afﬁnities. However, we have previ-
ously used the deoxygenation of oxymyoglobin or oxyleghaemoglobin
devised by Bergersen and Turner [66] to measure reliably the afﬁnities
of each of these oxidases in situ [32,67]. Using this method, we deter-
mined the Km of E. coli membrane particles containing cytochrome bo′
as the only terminal oxidase to be 0.2 μM and 0.46 μMwith each globin
respectively [67], whereas E. coli membrane particles containing only
cytochrome bd had much higher oxygen afﬁnity, with a Km of 5.8 nM
determined using leghaemoglobin [32].
Here we report the application of a similar method to obtain for the
ﬁrst time the oxygen afﬁnity of cytochrome bd-II in preparations that
contain only this oxidase. Fig. 6 shows the deoxygenation kinetics of
Fig. 3. A strain containing cytochrome bd-I as sole oxidase is more resistant to growth inhibition by CORM-3 than are strains expressing other oxidases. CORM-3 (12.5 μM) was
added at early exponential phase to cultures of E. coli as follows: (A) parent strain; (B) expressing cytochrome bd-I only; (C) expressing cytochrome bd-II only and (D) expressing
cytochrome bo′ only. Data in (A)–(D) show growth in the absence of any addition (closed symbols) and presence (open symbols) of CORM-3. Points are means and standard de-
viations of three biological replicates. (E) Shows the doubling times of these strains in the 2 h following CORM-3 addition, before (black bars) and after (grey bars) the addition of
CORM-3. These data are representative of three biological replicates.
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Precautions were taken to ensure (i) that the dual-wavelength absor-
bance measurements at the selected wavelengths were unaffected by
turbidity of the preparation, (ii) that the measured afﬁnities wereFig. 4. Cytochrome bd-I is resistant to respiratory inhibition by CORM-3. Membranes prepare
to an oxygen electrode chamber in sonication buffer (2 ml) to a ﬁnal concentration of appro
point at which CORM-3 (100 μM) was added is indicated by the ﬁrst, longer arrow in (A). Th
from the chamber 1 min later, indicated by the second arrow. The traces show dissolve
reoxygenate for the strains containing cytochrome bd-I only (black lines), cytochrome bd
from one representative experiment. (C) Shows the time to reoxygenation for each strain wi
dard deviations of at least 3 technical repeats.independent ofmembrane concentration and (iii) that the observed ab-
sorbance changes were due to deoxygenation, not globin oxidation, as
described previously [32]. The progress of deoxygenation was used to
calculate the fractional oxygenation of leghaemoglobin (Fig. 6A), fromd frommutants containing only one of the three terminal oxidases of E. coliwere added
ximately 370 μg/ml and stimulated to respire by the addition of NADH (12.5 mM). The
e control traces, in which no CORM-3 was added are shown in (B). The lid was removed
d oxygen in the chamber and indicate the times taken for the chamber to begin to
-II only (blue dotted lines) and the parent strain (red dashed lines). These data are
th CORM-3 (grey bars) or no additions (black bars). These data are the means and stan-
Fig. 5. Difference spectra of membrane particles expressing only a single oxidase. Membranes were prepared from E. coli respiratory mutants and diluted with buffer to a ﬁnal pro-
tein concentration of 8–19 mg/ml. Spectra were obtained 10 min after the addition of CORM-3 to membranes from the following strains: (A) wild type; (B) cytochrome bd-I only;
(C) cytochrome bd-II only; (D) cytochrome bo′ only. Data were plotted using a scanning dual beam spectrophotometer as the difference between the spectrum of a dithionite re-
duced sample incubated with 100 μM CORM-3 minus the spectrum of a reduced sample. Data have been smoothed in Sigma plot graphing software with a sampling proportion of
0.1 and a polynomial degree of 9.
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tion (Fig. 6B) and thence Lineweaver–Burk (Fig. 6C) and Eadie–Hofstee
(Fig. 6D) plots. The afﬁnity of cytochrome bd-II for oxygen (Km(O2))
was determined to be 0.24 μM (SD 0.019), with a Vmax value ofFig. 6. Determination of oxygen afﬁnity of cytochrome bd-II in membranes by the deoxygen
tion of membranes containing cytochrome bd-II as the only oxidase (reaction stimulated w
concentrations (S) were derived from the Appleby and Bergersen [77] equations. (C) Linewe
(Km(O2)) was determined to be 0.24 μM (SD 0.019), with a Vmax value of ~0.2 nmol s−1 m~0.2 nmol s−1 mg protein−1 (SD 0.02). The Km(O2) for cytochrome
bd-II calculated in this work is quoted in Table 1 alongside literature
values of the oxygen afﬁnity of other bacterial oxidases calculated by
this method.ation of oxyleghaemoglobin. (A) Deoxygenation of oxyleghaemoglobin during respira-
ith NADH, 3 mM ﬁnal concentration). (B) Oxygen consumption rates (V) and oxygen
aver–Burk plot and (D) Eadie-Hofstee plot. The afﬁnity of cytochrome bd-II for oxygen
g protein−1 (SD 0.02).
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does not prevent binding of CO from CORM-3 to the terminal oxidases
of E. coli
It is well documented that thiol-containing compounds such as
NAC prevent metal-containing CO-RMs from exerting their anti-
bacterial effects [22,31,46]. In particular, Desmard et al. [22] reported
that NAC prevents the inhibition of respiration by CORM-3 in
P. aeruginosa cultures. Here we report that NAC prevents the inhibi-
tion of respiration by both CORM-2 and CORM-3 in membrane parti-
cles prepared from wild type E. coli (Fig. 7). Fig. 7A shows an open
oxygen electrode experiment in which the time taken for the elec-
trode chamber to reoxygenate is measured in the presence of respir-
ing wild-type E. coli membrane particles and, where indicated, with
CORM-3 in the presence or absence of NAC. The addition of CORM-3
(400 μM) caused the chamber to reoxygenate immediately, indicat-
ing that respiration was inhibited (Fig. 7A, blue dashed line). Howev-
er, when NAC (400 μM) was added prior to CORM-3, respiration was
protected so that the time taken for the chamber to reoxygenate was
restored to 87% of the control time in which no inhibitor was added.
NAC was added to the chamber in the absence of CORM-3 and
found to cause reoxygenation in 74% of the time taken under control
conditions.
Closed oxygen electrode measurements conﬁrmed the ﬁnding that
100 μMNACprotects E. colimembrane particles from respiratory inhibi-
tion by the same concentration of CORM-3 (Fig. 7B). The respiration rate
of membrane particles 2 min after the addition of CORM-3 (400 μM)
was 167 nmol min−1 mg−1 compared to 442 nmol min−1 mg−1 in
the absence of inhibitor and 418 nmol min−1 mg−1 in the presence
of CORM-3 and NAC. Furthermore, NAC also reduces respiratory inhibi-
tion of E. colimembrane particles by CORM-2, but here a 10-fold excess
of NAC is needed in order to reduce the inhibitory effect of CORM-2
by approximately 50% (Fig. 7C). The respiration rate of membrane
particles 2 min after the addition of CORM-2 (50 μM) was
139 nmol min−1 mg−1 compared to 452 nmol min−1 mg−1 in the
absence of inhibitor and 276 nmol min−1 mg−1 in the presence of
CORM-2 and NAC.
We considered the possibility that NAC prevented the interaction
between the terminal oxidases and CO from CORM-3. Difference
spectra (i.e. the difference between the spectrum of a CORM-3-
reacted and reduced sample minus the spectrum of a reduced sam-
ple) were collected in both the absence (Fig. 8A) and presence
(Fig. 8B) of a 10-fold excess of NAC and found to have a peak at ap-
proximately 420 nm and a trough at approximately 446 nm in addi-
tion to a peak at approximately 644 nm. As in Fig. 5, the last is
diagnostic of the CO-bound cytochrome d of E. coli [49], while the
Soret features are attributed to CO binding to haems d and b595. Im-
portantly, the intensity of these features was not signiﬁcantly altered
in the presence of NAC (Fig. 8B), conﬁrming that this compound does
not interfere with the binding of CO released from CORM-3 with the
terminal oxidases of E. coli. This concurs with the ﬁndings of DesmardTable 1
Oxygen afﬁnities of selected bacterial terminal oxidases as determined by the deoxy-
genation of globins.
Bacterium and oxidase Km(O2) (μM) Reference
E. coli cytochrome bd-II 0.24 This work
E. coli cytochrome bd-I 0.003–0.008 [32]
Azotobacter vinelandii cytochrome bd 4.5 [54]
Klebsiella pneumoniae cytochrome bd 0.02 [74]
Campylobacter jejuni cytochrome bd
(cio or cyanide insensitive oxidase)
0.8 [75]
E. coli cytochrome bo′ 0.016–0.35 [67]
Campylobacter jejuni cytochrome cb’ 0.04 [75]
Bradyrhizobium japonicum cbb3-type oxidase 0.007 [76]et al. [46] who concluded that, as the activities of different CO-RMs
are affected differently by thiol compounds, it is unlikely that these
compounds have downstream effects such as affecting the interaction
of CO with cytochromes.
3.5. The antioxidant properties of NAC do not abolish the inhibition of
respiration by CORM-3
It has been proposed that NAC prevents the effects of CORM-3 by
virtue of its antioxidant properties [31]. To explore this hypothesis,
we investigated whether other antioxidants that do not contain
thiol groups were able to prevent the inhibition of respiration by
CORM-3. Ubiquinol (200 μM) (Fig. 9A) was able to decrease the inhi-
bition of respiration by 400 μMCORM-3 (by 36% compared to the rate
2 min after the addition of CORM-3), but not to the same extent as
NAC (400 μM, which caused a 60% decrease in inhibition compared
to the rate 2 min after the addition of CORM-3) (Fig. 7B). When
ubiquinol was added to the oxygen electrode chamber in the absence
of CORM-3, respiration was stimulated slightly, which is consistent
with the role of this compound in carrying electrons to the terminal
oxidases and could account to some extent for the decreased in-
hibition when ubiquinol and CORM-3 were added simultaneously.
Another antioxidant, ascorbate (1 mM) caused no reduction in the in-
hibition of respiration by CORM-3 (Fig. 9B). Ubiquinol and ascorbate
both have a redox potential of +60 mV [68], and therefore their
different effects on the ability of CORM-3 to inhibit respiration are un-
likely to be explained by this property. Finally, superoxide dismutase
(SOD, 250 units) was added to the chamber prior to the addition of
CORM-3, as it was expected that, if superoxide were generated by
the inhibition of respiration by CORM-3, SOD would convert it to ox-
ygen, which would be seen as an upward deﬂection of the oxygen
electrode trace [69]; however this was not seen (Fig. 9C), suggesting
that biologically relevant concentrations of superoxide do not accu-
mulate when respiration is inhibited by CORM-3. In addition, the
presence of SOD did not signiﬁcantly reduce the degree of inhibition
experienced by E. coli membrane particles treated with CORM-3.
3.6. NAC prevents the uptake of CORM-2 and CORM-3 into bacterial cells
Since reaction of CORM-3-derived CO with the terminal oxidases in
membranes is not prevented by NAC (Fig. 8), we tested the hypothesis
that NAC reduces the uptake of CORM-2 and CORM-3 by E. coli bymea-
suring intracellular ruthenium content at various time points after
treatment with either the CO-RM alone, or the CO‐RM in the presence
of a 10-fold excess of NAC. Following treatment of cultures of E. coli
with sub-lethal concentrations of CORM-3 (40 μM; Fig. 10A) or
CORM-2 (20 μM; Fig. 10B), ruthenium rapidly accumulates to approxi-
mately 8 and 30 times the concentration outside the cell respectively.
However, the uptake of these CO-RMs by wild type E. coli cells was dra-
matically reduced by NAC, by approximately 8-fold for CORM-3
(Fig. 10A) and approximately 5-fold for CORM-2 (Fig. 10B).
4. Discussion
Here, we explore the relative sensitivities of strains expressing each
of the three quinol oxidase protein complexes of E. coli to inhibition by
CO and CO-RMs. The latter are ﬁnding increasing application in physio-
logical studies of higher organisms and CO-RMs are being considered as
potential antimicrobial agents. It is becoming clear that CO gas and
CO-RMs have different modes of action against many bacterial process-
es; therefore, although there is an extensive literature on the interac-
tions of cytochromes bd-I and bo′ (but not bd-II) with CO gas and
other ligands, it cannot be assumed that oxidases will respond similarly
to CO-RMs. It seems likely that the bactericidal effects of CO-RMs are at-
tributable to interaction with cellular processes and molecules that are
distinct from those targeted by antibiotics, so that the use of CO-RMs
Fig. 7. NAC prevents CORM-2 and CORM-3-dependent inhibition of respiration in E. coli membrane particles. Wild type E. coli membrane particles were added to sonication buffer
(2 ml) to a ﬁnal concentration of approximately (A) 1490 μg/ml, (B) 70 μg/ml or (C) 100 μg/ml and respiration was initiated by the addition of NADH (6.25 mM). In (A), the lid was
removed from the chamber 1 min after the addition of CORM-3; arrows indicate the addition of NAC or CORM-3 (both at 400 μM); the traces show dissolved oxygen in the open
chamber for uninhibited respiration (black solid lines) or oxygen consumption in the presence of CO-RM (blue dashed lines), CO-RM and NAC (red dotted lines) or NAC alone (red
dot dash line). The time taken for the chamber to reoxygenate (given in min in parentheses) was measured for the various conditions: with no additions (35); with CORM-3 (0);
with NAC and CORM-3 (33); with NAC alone (28). In (B) and (C), a conventional closed oxygen electrode apparatus was used, uninhibited respiration is indicated by the black solid
lines, oxygen consumption in the presence of CO-RM by the blue dashed lines and that in the presence of CO-RM and NAC by the red dotted lines. In (B), arrows indicate the addition
of NAC or CORM-3 (both at 400 μM). In (C), arrows indicate the addition of NAC (500 μM) or CORM-2 (50 μM). In (B) and (C), respiration rates (nmol min−1 mg−1 protein) 2 min
following the addition of (B) CORM-3 and (C), CORM-2 are shown on adjacent to each trace. These data are representative of at least 3 technical and 2 biological replicates.
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most respiration measurements, since this is a water-soluble CO-RM
that has been extensively characterised by others and ourselves (for ref-
erences, see Introduction).
Previous transcriptomic data with E. coli [18] demonstrated the
down-regulation by CORM-3 of the cyo genes encoding cytochrome
bo′ and modest up-regulation of the cydAB genes encoding cyto-
chrome bd-I; the effects on the appBC genes encoding cytochrome
bd-II were not revealed. Further analyses demonstrated that the tran-
scription of appBC is unaltered after addition for CORM-3 over
80 min, whereas expression of the cydAB genes was increased initial-
ly, followed by a decrease (~3-fold down). This might suggest a role
for cytochrome bd-I in resisting CORM-3. The cyo genes appeared to
be most responsive to CORM-3 treatment with a fast and sustained
down-regulation (as low as ~50-fold decrease) over 80 min [47].
Here we show that a strain expressing only cytochrome bd-I is more
resistant to CORM-3 than are strains expressing only cytochromes
bo′ or bd-II. Cytochrome bd-I is also reported to protect the cell
from various environmental stresses such as cyanide, azide and diva-
lent metal ions [59] and cytochrome bd-I null mutants are more sen-
sitive to hydrogen peroxide than are wild type cultures [70].
Signiﬁcantly, cytochrome bd-I has been shown to protect E. coli
from NO-induced growth inhibition [57]. Explanations have been
sought in the ligand-binding kinetics of cytochromes bd-I and bo′.
The Kd (NO) is 4.4 nM for cytochrome bo′ but 0.55 nM for cyto-
chrome bd [57]. However, the basis of the relative insensitivity ofFig. 8. Effect of NAC on the reaction of the terminal oxidases in wild type E. coli membrane
buffer to a ﬁnal concentration of approximately 10 mg/ml and incubated with (A) CORM-3 (
were obtained 5 min after the addition of CORM-3 to membranes using a scanning dual be
dithionite reduced sample incubated with CORM-3 minus the spectrum of a reduced sample
of 0.1 and a polynomial degree of 9.cytochrome bd to NO appears to be the fast koff (0.163 s−1) [57],
5-fold faster than that observed with NO for cytochrome bo′
(0.03 s−1) and indeed almost all haem proteins. Interestingly, NO
also up-regulates cydAB expression [71], as does (slightly) CO [18].
In the case of CO, the apparent Kd value for cytochrome bd in mem-
branes appears to be ~70 nM (based on amethod that involves observ-
ing the distribution of CO between the oxidase and myoglobin) [61]
compared to 1.7 μM for cytochrome bo′ [62]. For cytochrome bd, the
koff is 6 or 1.6 s−1 according to themethod used [72]. The experimental-
ly determined Kd is consistent with the faster ‘off ‘rate of 6 s−1 [61].
Seeking an explanation of the CO‐RM data by comparing the koff for
CO from cytochromes bd and bo′ is complicated by literature disagree-
ments. Cheesman et al. [62] report a Koff (CO) value of ‘b10 s−1’ for cy-
tochrome bo′, but the dependence of the pseudo-ﬁrst-order rate upon
CO concentration suggests a value around 1 s−1. Subsequent citing of
these data, however, gives a Koff (CO) value of 0.1 s−1[73].
In summary, whereas the insensitivity of cytochrome bd to NO ap-
pears to be explained by the fast koff, no simple analysis of the ‘off
rates’ for CO from the two oxidases is possible. If we accept a koff of
6 s−1 for cytochrome bd [72] then the published data for cytochrome
bo′ are either very similar (b10 s−1) [62] or signiﬁcantly lower
(0.1 s−1) [73] and the differential sensitivity to CORM-3 is not readily
explained by their reactivities with CO gas alone. The afﬁnity of cyto-
chrome bd-II for CO has not been reported. These difﬁculties support
our contention (see Introduction) that sensitivity of cellular processes to
CO-RMs cannot be predicted solely on the basis of the response to CO gas.particles with CORM-3. Wild type E. coli membrane particles were added to sonication
100 μM) and (B) CORM-3 (100 μM) pre-incubated for 5 min with NAC (1 mM). Spectra
am spectrophotometer. Data were plotted as the difference between the spectrum of a
. Data have been smoothed in Sigma plot graphing software with a sampling proportion
Fig. 9. Antioxidants and superoxide dismutase (SOD) do not prevent CORM-3-
dependent inhibition of respiration to the same extent as thiol compounds. Wild
type E. coli membrane particles were added to the oxygen electrode in sonication
buffer (2 ml) to a ﬁnal concentration of approximately 60 μg/ml in (A) and 100 μg/
ml in (B). The chamber was closed and respiration was initiated by the addition of
6.25 mM NADH. The ﬁrst arrows in each panel indicate the addition of the antioxi-
dant or enzyme: (A) ubiquinol (100 μM); (B) ascorbate (1 mM); (C) SOD
(250 units) to the chamber, while the second arrows indicate the addition of
CORM-3 (400 μΜ). The black solid lines show the uninhibited respiration rate, the
blue dashed lines show oxygen consumption in the presence of CORM-3 and the
red dotted lines show oxygen consumption in the presence of CORM-3 and the anti-
oxidant (A and B) or SOD (C). In (A), the red dot dash line shows oxygen consumption
in the presence of ubiquinol alone. Respiration rates (nmol min−1 mg−1 protein)
2 min following the addition of CO-RM are shown adjacent to each trace. Traces are
representative of 2 biological replicates, each with 3 technical replicates.
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and bd-II is evident from consideration of afﬁnities for oxygen. The
former has long been considered to have an exceptionally high afﬁn-
ity, with Km values as low as 3–8 nM being reported for respiring cells
and membranes of E. coli in which cytochrome bd-I was the dominant
oxidase [32] (Table 1). However, the near identity of the spectral sig-
natures of cytochromes bd-I and bd-II [60] does not allow reliable
conclusions to be drawn about the oxygen afﬁnity of the latter. Mea-
surements of the Km of cytochrome bd-II for oxygen were published
recently [37] but were performed using a membrane-covered Clark
electrode with inadequate sensitivity in the nanomolar range. The
value cited for cytochrome bd-II (2 μM) therein was almost 10-fold
higher than the value reported in the present work. Furthermore, the
Km for bd-I was almost 100-fold higher than previous determinations
using the globin deoxygenation method [32] (Table 1). Both papers
agree, however, on the much higher oxygen afﬁnity of cytochrome
bd-I. The values published for assays that have used the sensitive globin
deoxygenationmethod are summarised in Table 1. The Km(O2) for E. coli
cytochrome bd-II is clearly much higher than those reported for E. coli
cytochrome bd-I and several other oxidase classes. The function of cyto-
chrome bd-II in E. coli is currently unknown.
We attribute the different susceptibilities of whole cells [21] and
membrane particles as reported in the current work, to the abilityFig. 10. NAC signiﬁcantly reduces the uptake of CORM-2 and CORM-3 into bacterial cells. Cul
of 20 ml samples both before, and at regular intervals after, the addition of CO-RM. In (A) R
bols) of 400 μMNAC is shown. In (B) Ru uptake as CORM-2 (20 μM) in the absence (closed s
for Ru content by inductively coupled plasma mass spectrometry. Data are the means andof CO gas to access the terminal oxidases of the respiratory chain
more easily in membrane particles. In addition, it is known that CO
release from CORM-3 is markedly promoted in the presence of com-
pounds such as dithionite or sulﬁte [44]. We have suggested that in-
tracellular compounds like sulﬁte might promote CO release from
CORM-3 after internalisation, which may explain why higher concen-
trations of CORM-3 are required in order to observe inhibition of res-
piration in membrane particles.
In the present work, we have achieved increased understanding
of the striking ability of NAC to abrogate the inhibitory effects of
CO-RMs. Because the literature shows thiol compounds to be effec-
tive in reducing the toxicity of several metal-containing CO-RMs
[22,31,46], both CORM-2 and CORM-3 were used for this part of the
present work. Here we show (i) that the antioxidant activity of
NAC is not key to this property, (ii) NAC does not prevent CO release
to terminal oxidase targets, and (iii) that uptake of CORM-2 and
CORM-3 is severely inhibited by the presence of this compound.
This reduced uptake is likely to contribute to the efﬁcacy of NAC
against the activity of some CO-RMs in a number of microbial and
cell culture studies. It is interesting that in the presence of NAC and
CORM-3, ruthenium accumulates inside the cell to only approxi-
mately the same concentration that is present outside the cell. A pos-
sible explanation for this is that NAC reacts with CORM-3 rendering
it unable to be transported against a concentration gradient into
the bacterial cell under these conditions. However we know nothing
about how CO-RMs are transported and release CO inside cells (the
“Trojan Horse” [21]). Our transcriptomic study of the effects of
CORM-3 has revealed in E. coli dramatic up-regulation of themdtABC
genes, encoding an RND-family multidrug efﬂux pump, and spy,
encoding a membrane-stress-responsive protein [18,47]. This impli-
cates a transport response to CORM-3, different from the bacterial
response to CO gas, and a clue to the bactericidal effectiveness of
CORM-3. In the absence of any molecular information on the mecha-
nism(s) of CO-RM uptake by cells, further comments can be only
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